Authors of a report released by the Institute of Medicine (IOM) on sodium intake by the American public failed to be persuaded that lowering daily consumption below 2,300 mg a day affected outcomes. The American Heart Association (AHA) countered the report missed the mark in its conclusions.
Patients implanted with dual-chamber implantable cardioverter-defibrillators (ICDs) had higher rates of complications at one year than did patients who received single-chamber devices, with no apparent benefits in hospitalization or mortality. The results were published in the May 15 issue of the Journal of the American Medical Association.
Quantifying body fat and other clinical factors in obese patients with diabetes using CT or magnetic resonance (MR) may help physicians detect and manage comorbidities such as cardiovascular disease, according to a review published in the May issue of Diabetes Technology & Therapeutics. But is that enough to justify “one-stop shop” imaging?
Ranbaxy has agreed to pay $500 million to settle a whistleblower lawsuit that claimed the pharmaceutical manufacturer made and distributed adulterated drugs at two facilities in India. The payment includes $350 million as a civil settlement plus $150 million in criminal fines.
Implementing standards on length of stay after PCI procedures reduced the percentage of patients kept overnight by more than half, authors of a poster reported May 9 at the Society of Cardiovascular Angiography and Interventions (SCAI) scientific sessions in Orlando, Fla.